Tags : Presage

BMS Signs a Research Collaboration with Presage to Evaluate Novel

Shots: Presage and BMS enter into a research collaboration to assess early stage oncology targets in P-0 studies by evaluating patients’ unique responses to micro doses of multiple cancer therapies The focus of the collaboration is to expand the use of Presage’s CIVO technology in P-0 studies and is the third partnership of Presage for […]Read More

Celgene Collaborates with Presage to Evaluate Therapies with its CIVO

Shots: Presage utilizes its CIVO intratumoral microdosing platform to evaluate Celgene’s early stage products in P-0 trial The collaboration follows safety & feasibility of CIVO in sarcoma patients, a clinical trial conducted by Presage which demonstrated well-tolerated data and the results are expected to be published in H2’19 Presage’s CIVO platform is an intratumoral microdosing […]Read More